Literature DB >> 11571937

Neuroendocrinology of stress.

K E Habib1, P W Gold, G P Chrousos.   

Abstract

Stimuli that are interpreted by the brain as extreme or threatening, regardless of their modality, elicit an immediate stereotypic response characterized by enhanced cognition, affective immobility, vigilance, autonomic arousal and a global catabolic state. The brain's ability to mobilize this so-called stress response is paralleled by activation of corticotropin-releasing hormone (CRH) in several nuclei, including the hypothalamus, amygdala and locus ceruleus, and stimulation of the locus ceruleus norepinephrine (LC/NE) system in the brain stem. These systems perpetuate one another, interact with several other transmitter systems in the brain and directly activate the hypothalamic-pituitary-adrenal (HPA) axis and the three components of the autonomic nervous system, namely the sympatho-adrenal, the cranio-sacral parasympathetic and the enteric nervous systems. The widespread body system responses to stress are discussed, and the implications of aberrant stress system activity on physical and mental health are outlined. Moreover, the promise of nonpeptide CRH type-1 receptor antagonists to directly target the stress system in the brain is highlighted.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11571937     DOI: 10.1016/s0889-8529(05)70208-5

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  80 in total

1.  Central infusion of ovine CRF (oCRF) potentiates defensive behaviors in CD-1 mice in the Mouse Defense Test Battery (MDTB).

Authors:  Mu Yang; Catherine Farrokhi; Amy Vasconcellos; Robert J Blanchard; D Caroline Blanchard
Journal:  Behav Brain Res       Date:  2006-04-18       Impact factor: 3.332

2.  Circuitry underlying regulation of the serotonergic system by swim stress.

Authors:  Michelle Roche; Kathryn G Commons; Andrew Peoples; Rita J Valentino
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

3.  Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety.

Authors:  Soyong Jang; Donghyun Kim; Yeonju Lee; Sohyeon Moon; Seikwan Oh
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

Review 4.  The Adaptive Calibration Model of stress responsivity.

Authors:  Marco Del Giudice; Bruce J Ellis; Elizabeth A Shirtcliff
Journal:  Neurosci Biobehav Rev       Date:  2010-12-08       Impact factor: 8.989

Review 5.  Sex differences in physiological reactivity to acute psychosocial stress in adolescence.

Authors:  Sarah Ordaz; Beatriz Luna
Journal:  Psychoneuroendocrinology       Date:  2012-01-27       Impact factor: 4.905

6.  Maternal attenuation of hypothalamic paraventricular nucleus norepinephrine switches avoidance learning to preference learning in preweanling rat pups.

Authors:  Kiseko Shionoya; Stephanie Moriceau; Peter Bradstock; Regina M Sullivan
Journal:  Horm Behav       Date:  2007-06-29       Impact factor: 3.587

Review 7.  The overtraining syndrome in athletes: a stress-related disorder.

Authors:  A Angeli; M Minetto; A Dovio; P Paccotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

8.  The impact of peri-operative dexamethasone administration on the normal hypothalamic pituitary adrenal response to major surgical procedures.

Authors:  Katia El-Sibai; Aman Rajpal; Ribal Al-Aridi; Warren R Selman; Baha M Arafah
Journal:  Endocrine       Date:  2017-09-01       Impact factor: 3.633

Review 9.  Attenuated hypothalamo-pituitary-adrenal axis responses to immune challenge during pregnancy: the neurosteroid opioid connection.

Authors:  Paula J Brunton; John A Russell
Journal:  J Physiol       Date:  2007-11-08       Impact factor: 5.182

10.  A general enhancement of autonomic and cortisol responses during social evaluative threat.

Authors:  Jos A Bosch; Eco J C de Geus; Douglas Carroll; Annebet D Goedhart; Leila A Anane; Jet J Veldhuizen van Zanten; Eva J Helmerhorst; Kate M Edwards
Journal:  Psychosom Med       Date:  2009-09-24       Impact factor: 4.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.